Literature DB >> 16998774

Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?

Terri B Hyde1, Deanna Kruszon-Moran, Geraldine M McQuillan, Cynthia Cossen, Bagher Forghani, Susan E Reef.   

Abstract

After the 1989-1991 rubella resurgence, rubella vaccination efforts targeted children and women of childbearing age. Utilizing National Health and Nutrition Examination Survey data collected during 1988-1994 and 1999-2004, we assessed whether US levels of rubella seropositivity are consistent with rubella elimination and whether changes are consistent with immunization efforts. Serum samples with rubella antibody levels > or =10 IU tested by rubella immunoglobulin G enzyme immunoassay were considered to be positive. In 1999-2004, the overall age-adjusted rubella seropositivity level was 91.3% (95% confidence interval [CI], 90.5%-92.1%), a significant increase from 88.1% (95% CI, 86.9%-89.1%) in 1988-1994 (P<.001). Among children, seropositivity was highest in children 6-11 years of age (96.2%), followed by adolescents 12-19 years of age (93.7%). Both groups showed significant increases in immunity levels, in comparison with those in 1988-1994 (P<.001). Among adults, seropositivity among women increased (from 88.9% to 91.5%; P=.015), and there was no change among men (from 87.8% to 88.0%; P=.84). In 1999-2004, population rubella immunity levels were at or above the modeled threshold for elimination of rubella virus transmission. Increases in immunity levels are consistent with vaccination efforts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998774     DOI: 10.1086/505947

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.

Authors:  George K Siberry; Kunjal Patel; William J Bellini; Brad Karalius; Murli U Purswani; Sandra K Burchett; William A Meyer; Sun Bae Sowers; Angela Ellis; Russell B Van Dyke
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

2.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

3.  Rubella immunity among pregnant women in a Canadian provincial screening program.

Authors:  Mark J Kearns; Sabrina S Plitt; Bonita E Lee; Joan L Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 4.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

5.  Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010.

Authors:  Emmaculate J Lebo; Deanna M Kruszon-Moran; Mona Marin; William J Bellini; Scott Schmid; Stephanie R Bialek; Gregory S Wallace; Huong Q McLean
Journal:  Open Forum Infect Dis       Date:  2015-02-20       Impact factor: 3.835

6.  Measles and Rubella Seroprevalence in Mother-Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations.

Authors:  Alastair F Murray; Janet A Englund; James M Tielsch; Joanne Katz; Laxman Shrestha; Subarna K Khatry; Kristen Carlin; Steven C Leclerq; Mark C Steinhoff; Helen Y Chu
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

7.  Rubella immunity among prenatal women in Ontario, 2006-2010.

Authors:  Gillian H Lim; Tara Harris; Shalini Desai; Natasha S Crowcroft; Tony Mazzulli; Tina Kozlowski; Shelley L Deeks
Journal:  BMC Infect Dis       Date:  2013-08-02       Impact factor: 3.090

8.  [Seroprevalence of rubella in Colombia: a birth-year cohort analysis].

Authors:  Doracelly Hincapie-Palacio; Viviana Lenis Ballesteros; Martha Ospina Ospina; Olga Lucía Pérez Toro; Francisco J Díaz
Journal:  Rev Saude Publica       Date:  2013-12       Impact factor: 2.106

9.  Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger.

Authors:  Shuk Yi Annie Hui; Daljit S Sahota; Terence T Lao
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

10.  Serum Concentration of Antibodies to Mumps, but Not Measles, Rubella, or Varicella, Is Associated with Intake of Dietary Fiber in the NHANES, 1999-2004.

Authors:  Cynthia B Van Landingham; Debra R Keast; Matthew P Longnecker
Journal:  Nutrients       Date:  2021-03-02       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.